Published in J Urol on September 01, 1982
Prophylaxis in urological surgery. Infection (1992) 0.75
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet (2001) 6.11
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol (1997) 3.45
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas. Eur J Cancer (2002) 3.26
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J Clin Oncol (2005) 2.39
Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer (1996) 2.06
Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects. J Pharm Sci (1977) 1.85
Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. Scand J Urol Nephrol Suppl (1995) 1.83
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy. Eur J Cancer (2003) 1.70
Urodynamic and histological correlates of benign prostatic hyperplasia. J Urol (1988) 1.59
Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br J Cancer (2001) 1.42
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer (2002) 1.41
Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases. J Cutan Pathol (1996) 1.40
Rosamicin--a new drug for the treatment of bacterial prostatitis. Antimicrob Agents Chemother (1977) 1.37
Interval appendectomy. A retrospective study. Acta Chir Scand (1979) 1.34
Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up. Urology (1990) 1.32
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. Antimicrob Agents Chemother (1987) 1.25
Netilmicin pharmacokinetics after single intravenous doses to elderly male patients. Antimicrob Agents Chemother (1977) 1.23
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials. J Urol (1970) 1.18
A future for hyperthermia in cancer treatment? Eur J Cancer (2001) 1.17
The importance of the pressure in the prostatic fossa and absorption of irrigating fluid during transurethral resection of the prostate. J Urol (1973) 1.16
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2002) 1.16
3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol (1986) 1.15
Rosamicin in urethral and vaginal secretions and tissues in dogs and rats. Antimicrob Agents Chemother (1977) 1.15
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Antimicrob Agents Chemother (1980) 1.15
Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion. Scand J Infect Dis Suppl (1978) 1.14
The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys (1996) 1.11
Pharmacokinetics of cefamandole in patients with normal and impaired renal function. Antimicrob Agents Chemother (1977) 1.11
Analysis of presenting symptoms in prostatism. J Urol (1984) 1.09
Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection. J Urol (1971) 1.08
Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrob Agents Chemother (1983) 1.08
Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs. Invest Urol (1979) 1.07
Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother (1979) 1.06
Scrotal herniation of the lower urinary tract. J Urol (1967) 1.05
Prognostic factors in soft tissue sarcomas: the Aarhus experience. Eur J Cancer (1998) 1.05
Route and prophylaxis of ascending bladder infection in male patients with indwelling catheters. J Urol (1972) 1.03
Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab (1997) 1.03
Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics. Antimicrob Agents Chemother (1975) 1.01
Isolation and biological activity of aspidospermine and quebrachamine from an Aspidosperma tree source. J Pharm Biomed Anal (1994) 1.01
Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans. Antimicrob Agents Chemother (1973) 1.01
Treatment of urinary tract infections with cefotaxime: noncomparative and prospective comparative trials. Rev Infect Dis (1983) 1.00
Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole: experimental and clinical studies. Urology (1976) 0.99
Intravenous administration of sodium colistimethate in urinary tract infections. Curr Ther Res Clin Exp (1967) 0.98
High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue. Antimicrob Agents Chemother (1986) 0.98
Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections. Antimicrob Agents Chemother (1978) 0.97
Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am (1986) 0.97
Significance of prostatic weight in prostatism. Urol Int (1983) 0.96
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1999) 0.94
Functional outcome in sarcomas treated with limb-salvage surgery or amputation. Sarcoma (1998) 0.93
Bacterial prostatitis: new methods of treatment. Urology (1991) 0.92
Experimental lipid A-induced nephritis in the dog. Invest Urol (1975) 0.92
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. Cancer Chemother Pharmacol (1991) 0.92
Cefamandole and cefazolin in the therapy of complicated urinary tract infections. J Infect Dis (1978) 0.91
Posttraumatic priapism: successful treatment with autologous clot embolization. AJR Am J Roentgenol (1979) 0.90
The relevance of minimum urethral resistance in prostatism. J Urol (1983) 0.89
Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia. Urol Int (1995) 0.89
Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder. Invest Urol (1981) 0.89
Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate. J Urol (1989) 0.89
Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report. J Urol (1968) 0.89
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Antimicrob Agents Chemother (1981) 0.89
MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids. Infection (1991) 0.89
Malignant interstitial cell testicular tumor. Cancer (1973) 0.89
Palliative radiotherapy of bone metastases: there is now evidence for the use of single fractions. Radiother Oncol (1999) 0.88
Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. J Urol (1987) 0.88
Prophylactic antibiotics in transurethral prostatectomy. J Urol (1981) 0.87
Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay. Radiother Oncol (1995) 0.87
Sisomicin treatment of complicated urinary tract infections: efficacy, tolerance and pharmacokinetics. J Clin Pharmacol (1974) 0.87
Determination of absorption of irrigating fluid during transurethral resection of the prostate by means of radioisotopes. J Urol (1969) 0.87
Value of postvoid residual urine determination in evaluation of prostatism. Urology (1982) 0.86
The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia. Ann N Y Acad Sci (1980) 0.86
Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology (1995) 0.86
Aztreonam concentrations in human prostatic tissue. Antimicrob Agents Chemother (1984) 0.86
EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma. Sarcoma (1997) 0.86
Secretion of various antimicrobial substances in dogs with experimental bacterial prostatitis. Urol Res (1977) 0.85
Transurethral prostatic resection in the treatment of prostatism with high urinary flow. J Urol (1983) 0.85
Spontaneous uroflowmetry in prostatism. Urology (1984) 0.85
The significance of uninhibited detrusor contractions in prostatism. J Urol (1985) 0.84
Transurethral resection versus transurethral incision of the prostate. A prospective randomized study. Urol Clin North Am (1990) 0.83
Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Infection (1974) 0.83
Chronic bacterial prostatitis: theoretical and experimental considerations. Urol Res (1983) 0.83
Scanning electron microscopy of normal and malignant human urothelium. Urology (1976) 0.83
Renal lymph and interstitial fluid concentration of co-trimazine: an experimental study in dogs. Infection (1979) 0.83
Infectious complications after instrumentation of urinary tract. Urology (1985) 0.82
Antibiotics excretion in canine vaginal and urethral secretions. Invest Urol (1978) 0.82
Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids. Antimicrob Agents Chemother (1987) 0.82
Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin. J Urol (1983) 0.82
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer. Cancer Chemother Pharmacol (1991) 0.82
Pharmacokinetics of ampicillin and methoxymethyl ester of hetacillin in dogs. J Pharm Sci (1977) 0.82
Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries. Invest Radiol (1997) 0.82
Effect of in vitro X-irradiation on lymphocyte and granulocyte function. Scand J Haematol (1981) 0.82
Short-term cephalosporin prophylaxis in transurethral surgery. Clin Ther (1982) 0.81
Neoplasm to neoplasm metastasis. A renal oncocytoma with metastatic bronchogenic carcinoma. Scand J Urol Nephrol (1984) 0.81
Prostatic fluid and tissue concentrations of ampicillin after administration of hetacillin ester (BL-P1761). Invest Urol (1976) 0.81
Comparison of concentrations of rifampin and a new rifamycin derivative, DL 473, in canine bone. Antimicrob Agents Chemother (1983) 0.81
The EORTC soft tissue and bone sarcoma group. European Organisation for Research and Treatment of Cancer. Eur J Cancer (2002) 0.81